ARTIFICIAL intelligence strengthens clinical rheumatology care through automated ultrasound interpretation, targeted medical education, and decision support validation. Three separate investigations presented at ACR Convergence 2026, the annual meeting of the American College of Rheumatology, demonstrate how computational platforms can streamline inflammatory disease assessment while underscoring the critical necessity of clinician oversight.